Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Advanced Cancer × Dasatinib × Clear all

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 38 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 26 Leukemia, Myeloid, Chronic-Phase 15 Leukemia 15 Leukemia, Myeloid, Acute 14 Breast Neoplasms 12 Recurrence 10 Leukemia, Lymphocytic, Chronic, B-Cell 10 Prostatic Neoplasms 8 Neoplasm Metastasis 8 Carcinoma, Non-Small-Cell Lung 8 Lung Neoplasms 6 Burkitt Lymphoma 6 Blast Crisis 6 Pancreatic Neoplasms 5 Lymphoma, Non-Hodgkin 5 Glioblastoma 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Philadelphia Chromosome 4 Neoplasms 4 Myelodysplastic Syndromes 4 Multiple Myeloma 4 Leukemia, Myeloid, Accelerated Phase 4 Gliosarcoma 4 Glioma 4 Gastrointestinal Stromal Tumors 4 Colorectal Neoplasms 4 Waldenstrom Macroglobulinemia 3 Squamous Cell Carcinoma of Head and Neck 3 Neuroblastoma 3

Interventions

Surveys and Questionnaires 7 Bevacizumab 5 temsirolimus 4 Standard of Care 4 Sirolimus 4 Interviews as Topic 4 Vorinostat 2 Paclitaxel 2 Olanzapine 2 Magnetic Resonance Spectroscopy 2 Everolimus 2 Erlotinib Hydrochloride 2 Cetuximab 2 zaleplon 1 vistusertib 1 tilsotolimod 1 pazopanib 1 olaparib 1 olanzapine-fluoxetine combination 1 liposomal doxorubicin 1 capivasertib 1 apatinib 1 Videotape Recording 1 Vemurafenib 1 Valproic Acid 1 Trastuzumab 1 Topotecan 1 Temozolomide 1 Sunitinib 1 Sorafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00895128 2015-07-13

Study of Erlotinib in Combination With Dasatinib

M.D. Anderson Cancer Center

Phase 1 Completed

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡